Diagnostic value of serological tests against Pseudomonas aeruginosa in a large cystic fibrosis population

Thorax

Volumn 61, Issue 8, 2006, Pages 689-693

  Tramper Stranders, G A ^b   Van Der Ent, C K ^b   Slieker, M G ^b   Terheggen Lagro, S W J ^b   Teding Van Berkhout, F ^b   Kimpen, J L L ^a   Wolfs, T F W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PROTEINASE; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; ELASTASE; EXOTOXIN;

ADOLESCENT; ADULT; AGED; ANTIGEN PURIFICATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MEDICAL RESEARCH; NEWBORN; OROPHARYNX; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPUTUM CULTURE;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CYSTIC FIBROSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REFERENCE STANDARDS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33747041656     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.054726     Document Type: Article

References (22)

1. Emerson J, Rosenfeld M, McNamara S, et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 2002;34:91-100.
2. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001;32:277-87.
3. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
4. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005;293:581-8.
5. Frederiksen B, Koch C, Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997;23:330-5.
6. Ratjen F, Doring G, Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis. Lancet 2001;358:983-4.
7. Burns MW, May JR. Bacterial precipitins in serum of patients with cystic fibrosis. Lancet 1968;1:270-2.
8. Johansen HK, Norregaard L, Gotzsche PC, et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? A 30-year cohort study of survival in Danish CF patients after onset of chronic P aeruginosa lung infection. Pediatr Pulmonol 2004;37:427-32.
9. Pedersen SS, Espersen F, Hoiby N. Diagnosis of chronic Pseudomonas aeruginosa infection in cystic fibrosis by enzyme-linked immunosorbent assay. J Clin Microbiol 1987;25:1830-6.
10. Hollsing AE, Granstrom M, Vasil ML, et al. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol 1987;25:1868-74.
11. Brett MM, Ghoneim AT, Littlewood JM. Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol 1988;26:1565-70.
12. Burns JL, Gibson RL, McNamara S, et al. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 2001;183:444-52.
13. West SE, Zeng L, Lee BL, et al. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 2002;287:2958-67.
14. Hoiby N, Koch C. Maintenance treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis. Thorax 2000;55:349-50.
15. Tosi MF, Zakem-Cloud H, Demko CA, et al. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. J Infect Dis 1995;172:453-61.
16. Winnie GB, Cowan RG. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulmonol 1991;10:92-100.
17. Armstrong DS, Grimwood K, Carlin JB, et al. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. Pediatr Pulmonol 1996;21:267-75.
18. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999;28:321-8.
19. Lee TW, Brownlee KG, Conway SP, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
20. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 2003;29:1043-51.
21. Tramper-Stranders GA, van der Ent CK, Wolfs TF. Detection of Pseudomonas aeruginosa in patients with cystic fibrosis. J Cyst Fibros 2005;4(Suppl 2):37-43.
22. Granstrom M, Ericsson A, Strandvik B, et al. Relation between antibody response to Pseudomonas aeruginosa exoproteins and colonization/infection in patients with cystic fibrosis. Acta Paediatr Scand 1984;73:772-7.